Adderall, Benzedrine, Dexedrine, and Vyvanse are all central nervous system stimulants that contain amphetamine or dextroamphetamine salts. These medications are commonly prescribed to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy by increasing neurotransmitter activity in the brain.

Astelin, which contains the active ingredient azelastine, is a selective H1-receptor antagonist used as a nasal spray to alleviate symptoms of seasonal allergic rhinitis. The other medications listed, such as Tofranil, Wellbutrin, and Norpramin, are classified as antidepressants and are not indicated for the treatment of allergic reactions or respiratory inflammation.

The safety ratio, often referred to as the therapeutic index, measures the gap between the therapeutic dose and the toxic dose of a drug. A larger ratio indicates a wider margin of safety, meaning the drug is less likely to cause toxicity at doses near the therapeutic level.

Depressants are a class of drugs that slow down the activity of the central nervous system. They typically produce effects such as relaxation, sedation, and reduced anxiety. Common examples include alcohol, benzodiazepines, and barbiturates. They work by enhancing the effects of the neurotransmitter GABA in the brain.

Cocaine is a potent stimulant that affects the central nervous system. Its use can lead to a variety of adverse physiological reactions, including headaches due to vascular changes, abdominal pain resulting from gastrointestinal distress, and nausea. Because it acts as a sympathomimetic agent, it can cause systemic issues throughout the body, making all the listed symptoms potential side effects of its consumption.

The safety ratio, or therapeutic index, compares the dose of a drug that causes toxicity to the dose that causes the intended effect. Marijuana is often cited in literature as having a high safety ratio, approximately 1000, indicating a very wide margin between therapeutic and lethal doses.

Monoamine oxidase inhibitors (MAOIs) are a class of antidepressant medications. They work by inhibiting the enzyme monoamine oxidase, which breaks down neurotransmitters like serotonin, norepinephrine, and dopamine. By preventing this breakdown, MAOIs increase the availability of these neurotransmitters in the brain, effectively treating symptoms of clinical depression.

MDMA is a synthetic psychoactive drug that acts as both a stimulant and a hallucinogen. Chemically known as 3,4-methylenedioxymethamphetamine, it is known for producing feelings of increased energy, pleasure, emotional warmth, and distorted sensory and time perception. It is frequently studied in the context of substance use and, more recently, as a potential adjunct to psychotherapy for conditions like PTSD.

Marijuana use can lead to various subjective experiences, including feelings of euphoria, increased laughter or giggling, and a state of mild intoxication, which are common effects reported by users due to the impact of cannabinoids on the central nervous system.

Depressants, such as benzodiazepines or barbiturates, work by slowing down central nervous system activity. They are clinically utilized to reduce physiological arousal (heart rate), manage pain, and influence respiratory functions in specific medical contexts. Because they affect multiple bodily systems, they are often used for diverse therapeutic outcomes under strict medical supervision.